The second phase of vaccination has already started in India and people have already started to look out for the best vaccine they should take to protect themselves against the virus.
Covishield and Covaxin have already been the most famous vaccines in India, but recently another vaccine will be introduced in India known as the Sputnik V by the end of April. Sputnik V becomes the third Covid 19 vaccine to get clearance in India.
In this blog, we will be having a detailed comparison between Sputnik V, Covishield and Covaxin.
We will be taking certain factors into account for the comparison which includes
- The developer of the vaccines
- The type of the vaccine
- Doses required for the vaccine
- How to store the vaccines
- Mode of administration
- Who can take the vaccines?
Sputnik V Vs Covishield Vs Covaxin – The developer of the vaccines
Covishield has been developed by the Oxford-AstraZeneca and is manufactured in India by the Serum Institute of India (SII).
Sputnik V is a viral vector vaccine for Covid 19 which has been developed by Gamaleya Research Institute of Epidemiology and Microbiology. In India Dr. Reddy’s Laboratories has collaborated with the Russian sovereign fund Russian Direct Investment Fund (RDIF).
Sputnik V Vs Covishield Vs Covaxin – Type of Vaccine
Covaxin is made using an inactive version of the virus- i.e., the vaccine inactivates the virus’s ability to replicate but sustains its life so that the immune system could mount a sufficient response when it comes in contact.
Sputnik V is an adenoviral-based, two-part vaccine against the SARS-CoV-2 coronavirus. Sputnik V uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.
Sputnik V Vs Covishield Vs Covaxin – Doses
As already India is on the third phase of vaccination, Covishield and Covaxin have two doses officially, with a gap of 28 days from the first dose of vaccination.
On the other hand, Sputnik V, will also have two doses with the days gap being 21 days that is the second dose of the Sputnik V dose should be taken after 21 days of the first dose vaccination.
Sputnik V Vs Covishield Vs Covaxin – Storage
Sputnik V needs a storage temperature of 2-8 degree C, implying it can be stored in conventional refrigerators and does not require additional cold-chain infrastructure, making storage and transportation easy.
Both Covishield and Covaxin are stored at 2-8 degree centigrade, which is the normal refrigeration temperature in India.
This makes 3 of the vaccines suitable for the Indian climate.
Sputnik V Vs Covishield Vs Covaxin – Approval
The Drug Controller General of India (DCGI) approved the Sputnik V COVID-19 vaccine for emergency use on April 13.
Covaxin has been conceded a confined use approval in clinical preliminary mode, while Covishield has been taken into consideration limited use in crisis circumstances that can conceivably forestall Covid contamination in individuals. Both Covishield and Covaxin have been already approved.
Sputnik V Vs Covishield Vs Covaxin – Pricing
In government health setups both vaccines( Covishield and Covaxin) are declared as free of cost whereas in private hospitals the price is marked as Rs 250.
Globally RDIF has been selling Sputnik V at $10 per dose whereas In India the center has capped the prices of vaccines at Rs 150 per dose.
Sputnik V Vs Covishield Vs Covaxin – Mode of administration
Sputinik V, Covishield and Covaxin are intramuscular vaccines.
Sputnik V Vs Covishield Vs Covaxin – Who can take the vaccines?
Covishield has been approved for people aged 18 years and above, while Covaxin can be given to people aged 12 years and above. There, however, isn’t any assurance if the vaccine can be given to children and pregnant women. Sputnik V has not started its vaccination period yet it has also been approved for 18 years and above.
Sputnik V can be a great choice because of its cheap price, however, researches has still been continued due to its minor side effects. Covishield and Covaxin also have their own side effects such as fever, headaches, nausea but Sputnik V can be really a game-changer when it is launched in India.